Compositions and methods for modulating HEXIM1 expression
US11833124B2 · kind B2 · utility
0Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 30, 2021 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Dec 18, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inducing HEXIM1 expression in cells of a subject includes administering to the cells a compound having the formula, and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.